185 related articles for article (PubMed ID: 35697931)
21. [Influence of the HLDF differentiation factor on the production of cytokines by bio-tissues of breast tissue in its non-malignant diseases and in invasive carcinoma of a non-specific type].
Autenshlyus AI; Studenikina AA; Mikhaylova YS; Proskura AV; Varaksin NA; Sidorov SV; Bogachuk AP; Lipkin VM; Lyakhovich VV
Biomed Khim; 2020 Nov; 66(6):485-493. PubMed ID: 33372907
[TBL] [Abstract][Full Text] [Related]
22. Cell polarity and cell adhesion associated gene expression differences between invasive micropapillary and no special type breast carcinomas and their prognostic significance.
Kramer Z; Kenessey I; Gángó A; Lendvai G; Kulka J; Tőkés AM
Sci Rep; 2021 Sep; 11(1):18484. PubMed ID: 34531452
[TBL] [Abstract][Full Text] [Related]
23. [Mammary carcinoma with osteoclast-like giant cells--report of two cases].
Kajo K; Macháleková K; Kviatkovská Z
Cesk Patol; 2006 Apr; 42(2):71-5. PubMed ID: 16715631
[TBL] [Abstract][Full Text] [Related]
24. Osteoclast-like giant cells in invasive breast cancer predominantly possess M2-macrophage phenotype.
Ohashi R; Yanagihara K; Namimatsu S; Sakatani T; Takei H; Naito Z; Shimizu A
Pathol Res Pract; 2018 Feb; 214(2):253-258. PubMed ID: 29129494
[TBL] [Abstract][Full Text] [Related]
25. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
26. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
[TBL] [Abstract][Full Text] [Related]
27. [Genomic approaches to bone and joint diseases. Mutations of RANK, OPG and RANKL genes found in humans].
Kobayashi Y; Takahashi N
Clin Calcium; 2008 Feb; 18(2):202-9. PubMed ID: 18245890
[TBL] [Abstract][Full Text] [Related]
28. Undifferentiated carcinoma with osteoclast-like giant cells: A pathologic-radiologic correlation of a rare histologic subtype of pancreatic ductal adenocarcinoma.
Jain PV; Griffin M; Hunt B; Ward E; Tsai S; Doucette S
Ann Diagn Pathol; 2022 Apr; 57():151884. PubMed ID: 35074581
[TBL] [Abstract][Full Text] [Related]
29. Imbalanced expression of RANKL and osteoprotegerin mRNA in pannus tissue of rheumatoid arthritis.
Ainola M; Mandelin J; Liljeström M; Konttinen YT; Salo J
Clin Exp Rheumatol; 2008; 26(2):240-6. PubMed ID: 18565244
[TBL] [Abstract][Full Text] [Related]
30. Mammary carcinoma with osteoclast-like giant cells: a case report.
Albawardi AS; Awwad AA; Almarzooqi SS
Int J Clin Exp Pathol; 2014; 7(12):9038-43. PubMed ID: 25674284
[TBL] [Abstract][Full Text] [Related]
31. Metaplastic breast carcinomas display genomic and transcriptomic heterogeneity [corrected].
Weigelt B; Ng CK; Shen R; Popova T; Schizas M; Natrajan R; Mariani O; Stern MH; Norton L; Vincent-Salomon A; Reis-Filho JS
Mod Pathol; 2015 Mar; 28(3):340-51. PubMed ID: 25412848
[TBL] [Abstract][Full Text] [Related]
32. Osteoclast-like cells in soft tissue leiomyosarcomas.
Gibbons CL; Sun SG; Vlychou M; Kliskey K; Lau YS; Sabokbar A; Athanasou NA
Virchows Arch; 2010 Mar; 456(3):317-23. PubMed ID: 20127110
[TBL] [Abstract][Full Text] [Related]
33. Cholesterol inhibits autophagy in RANKL-induced osteoclast differentiation through activating the PI3K/AKT/mTOR signaling pathway.
Jiang C; Wang Y; Zhang M; Xu J
Mol Biol Rep; 2022 Oct; 49(10):9217-9229. PubMed ID: 35881223
[TBL] [Abstract][Full Text] [Related]
34. A case of pulmonary adenocarcinoma harboring osteoclast-like giant cells: Its evaluation by immunohistochemical and genetic analyses.
Saito R; Fujishima F; Nakamura Y; Hoshikawa Y; Tominaga J; Taniuchi S; Kasajima A; Watanabe M; Okada Y; Sasano H
Pathol Int; 2016 Apr; 66(4):224-9. PubMed ID: 26939759
[TBL] [Abstract][Full Text] [Related]
35. Genomic profiling of histological special types of breast cancer.
Horlings HM; Weigelt B; Anderson EM; Lambros MB; Mackay A; Natrajan R; Ng CK; Geyer FC; van de Vijver MJ; Reis-Filho JS
Breast Cancer Res Treat; 2013 Nov; 142(2):257-69. PubMed ID: 24162157
[TBL] [Abstract][Full Text] [Related]
36. M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase.
Glantschnig H; Fisher JE; Wesolowski G; Rodan GA; Reszka AA
Cell Death Differ; 2003 Oct; 10(10):1165-77. PubMed ID: 14502240
[TBL] [Abstract][Full Text] [Related]
37. p-mTOR expression is associated with better prognosis in luminal breast carcinoma.
Beca F; Andre R; Martins DS; Bilhim T; Martins D; Schmitt F
J Clin Pathol; 2014 Nov; 67(11):961-7. PubMed ID: 25053543
[TBL] [Abstract][Full Text] [Related]
38. Uterine leiomyosarcomas with osteoclast-like giant cells associated with high expression of RUNX2 and RANKL.
Terasaki M; Terasaki Y; Wakamatsu K; Kuwahara N; Yoneyama K; Kawase R; Kurose K; Toda E; Endo Y; Kunugi S; Kajimoto Y; Shimizu A
Virchows Arch; 2021 May; 478(5):893-904. PubMed ID: 33404854
[TBL] [Abstract][Full Text] [Related]
39. Neuroendocrine differentiation in breast carcinoma with osteoclast-like giant cells. Report of a case and review of the literature.
Cozzolino I; Ciancia G; Limite G; Di Micco R; Varone V; Cortese A; Vatrella A; Di Crescenzo V; Zeppa P
Int J Surg; 2014; 12 Suppl 2():S8-S11. PubMed ID: 25204617
[TBL] [Abstract][Full Text] [Related]
40. Asperolide A prevents bone metastatic breast cancer via the PI3K/AKT/mTOR/c-Fos/NFATc1 signaling pathway.
Jiang W; Rixiati Y; Huang H; Shi Y; Huang C; Jiao B
Cancer Med; 2020 Nov; 9(21):8173-8185. PubMed ID: 32976685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
